Agape ATP (NASDAQ:ATPC – Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a “hold” rating in a report issued on Saturday.
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Agape ATP currently has an average rating of “Sell”.
Get Our Latest Analysis on Agape ATP
Agape ATP Trading Up 8.7%
Institutional Investors Weigh In On Agape ATP
An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC lifted its position in Agape ATP Corporation (NASDAQ:ATPC – Free Report) by 95.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 65,130 shares of the company’s stock after buying an additional 31,849 shares during the quarter. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. 0.01% of the stock is currently owned by institutional investors.
About Agape ATP
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Read More
- Five stocks we like better than Agape ATP
- ALERT: Drop these 5 stocks before January 2026!
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Buy This Stock Now
- The Next Commodity Crunch (bigger than oil?)
- Silicon Valley insiders hint at 12-month AI warning
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
